2018
DOI: 10.1016/j.schres.2017.04.026
|View full text |Cite
|
Sign up to set email alerts
|

Mismatch negativity in bipolar disorder: A neurophysiological biomarker of intermediate effect?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
18
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 32 publications
(21 citation statements)
references
References 79 publications
3
18
0
Order By: Relevance
“…As reported in our previous study (Dima et al, 2012), the MMN amplitude was strongly reduced in patients with schizophrenia compared to typically developing subjects, while for bipolar disorder the MMN was intermediately reduced, in line with the findings of Hermens et al (Hermens et al, 2017). A recent meta-analysis (Erickson et al, 2015) found the effect size for MMN amplitude changes in schizophrenia were greater with disease progression, while that for bipolar disorder were smaller and similar to that seen in first episode schizophrenia.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…As reported in our previous study (Dima et al, 2012), the MMN amplitude was strongly reduced in patients with schizophrenia compared to typically developing subjects, while for bipolar disorder the MMN was intermediately reduced, in line with the findings of Hermens et al (Hermens et al, 2017). A recent meta-analysis (Erickson et al, 2015) found the effect size for MMN amplitude changes in schizophrenia were greater with disease progression, while that for bipolar disorder were smaller and similar to that seen in first episode schizophrenia.…”
Section: Discussionsupporting
confidence: 92%
“…Likewise, some studies have found common neurobiological disturbances in deviance detection/orienting processes (Kaur et al, 2011), others have reported deficits in pre-attentive auditory processing, 4 and MMN deficits that are less severe in bipolar disorder (Jahshan et al, 2012a). Hermens et al (Hermens et al, 2017) recently concluded that MMN was not a diagnosis specific biomarker.…”
Section: Introductionmentioning
confidence: 99%
“…Electroencephalography probes neural dysfunction more directly. Abnormalities in P300 amplitude and latency as well as mismatch negativity have been established in schizophrenia, clinical high risk states, schizotypal personality disorder, and bipolar disorder 182,192,231‐234 . This pattern suggests that P300 and mismatch negativity track thought disorder, but direct evidence of specificity is limited, and they may prove to be markers of the general psychosis superspectrum.…”
Section: Validity Evidencementioning
confidence: 99%
“…Another studied showed a contradictory finding in which their patients with bipolar disorder and major depressive disorder had no significant dMMN amplitude reduction ( 142 ). A review of the MMN study on the bipolar spectrum has proposed that bipolar disease could lead to an intermediate level reduction on MMN in-between those with schizophrenia and the healthy controls ( 143 ) although a systematic model is yet to be developed due to the unclear relationship between MMN and the subtypes (as well as medication status) of bipolar disorder ( 144 , 145 ). MMN for the major depressive disorder had also been investigated, yet again, the results were inconsistent across the literatures ( 146 148 ).…”
Section: Mismatch Negativity In Schizophreniamentioning
confidence: 99%